Literature DB >> 7487210

Clinical behavior and prognostic factors of periampullary adenocarcinoma.

C Chan1, M F Herrera, L de la Garza, L Quintanilla-Martinez, F Vargas-Vorackova, Y Richaud-Patín, L Llorente, L Uscanga, G Robles-Diaz, E Leon.   

Abstract

OBJECTIVE: The authors evaluated the outcome and potential prognostic factors of 60 patients with surgically resected periampullary tumors. SUMMARY BACKGROUND DATA: Periampullary carcinomas exhibit different clinical behaviors according to their site of origin. There are no prognostic factors for deciding the type of surgery to be used or for choosing patients with tumors that have a poor prognosis for adjuvant treatment.
METHODS: A retrospective review was performed of 15 clinical and pathologic variables encountered among 60 patients with periampullary tumors. Tumors were divided into four groups according to their site of origin. Kaplan-Meier survival curves of the four groups were plotted and differences were evaluated with the log-rank test. Cox's proportional hazards model was used to test for separate and combined independent predictors of disease-free survival.
RESULTS: Twenty-nine ampullary carcinomas, 20 ductal pancreatic carcinomas, 7 distal common bile duct carcinomas, and 4 carcinomas of the periampullary duodenum were found. Five-year disease-free survival was 43%, 0%, 0%, and 75%, respectively. According to the Cox analysis, absence of neural invasion and use of adjuvant chemotherapy were significant factors for longer survival of patients with ampullary tumors. Lymphatic invasion was related to a shorter survival in patients with pancreatic carcinoma.
CONCLUSIONS: Five-year disease-free survival of patients with periampullary tumors is related to tumor type. Prognosis was better for ampullary tumors if neural invasion was absent and if adjuvant chemotherapy was used. Lymphatic invasion was associated with a shorter recurrence-free survival among patients with pancreatic carcinoma.

Entities:  

Mesh:

Year:  1995        PMID: 7487210      PMCID: PMC1234990          DOI: 10.1097/00000658-199511000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  25 in total

1.  Survival in 1001 patients with carcinoma of the pancreas.

Authors:  M M Connolly; P J Dawson; F Michelassi; A R Moossa; F Lowenstein
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

2.  Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer.

Authors:  J L Cameron; D W Crist; J V Sitzmann; R H Hruban; J K Boitnott; A J Seidler; J Coleman
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

Review 3.  Pancreatic cancer in 1988. Possibilities and probabilities.

Authors:  A L Warshaw; R S Swanson
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

4.  Flow cytometric DNA measurements in benign and malignant Hürthle cell tumors of the thyroid.

Authors:  J J Ryan; I D Hay; C S Grant; L M Rainwater; G M Farrow; J R Goellner
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

5.  The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma.

Authors:  G Crile
Journal:  Surg Gynecol Obstet       Date:  1970-06

6.  Pancreatic cancer cell DNA content correlates with long-term survival after pancreatoduodenectomy.

Authors:  D C Allison; K K Bose; R H Hruban; S Piantadosi; W C Dooley; J K Boitnott; J L Cameron
Journal:  Ann Surg       Date:  1991-12       Impact factor: 12.969

7.  Carcinoma of the ampulla of Vater.

Authors:  Y L Matory; J Gaynor; M Brennan
Journal:  Surg Gynecol Obstet       Date:  1993-10

8.  Evaluation of DNA nuclear pattern as a prognostic determinant in resected pancreatic ductal adenocarcinoma.

Authors:  M F Herrera; J A van Heerden; J A Katzmann; L H Weiland; D M Nagorney; D Ilstrup
Journal:  Ann Surg       Date:  1992-02       Impact factor: 12.969

9.  Can survival in pancreatic adenocarcinoma be predicted by primary size or stage?

Authors:  J A Petrek; W A Sandberg; P K Bean; E L Bradley
Journal:  Am Surg       Date:  1985-01       Impact factor: 0.688

10.  Biliary carcinoma. A review of 109 cases.

Authors:  F Alexander; R L Rossi; M O'Bryan; U Khettry; J W Braasch; E Watkins
Journal:  Am J Surg       Date:  1984-04       Impact factor: 2.565

View more
  19 in total

1.  Superior prognostic importance of perineural invasion vs. lymph node involvement after curative resection of duodenal adenocarcinoma.

Authors:  Stefano Cecchini; Camilo Correa-Gallego; Vikram Desphande; Matteo Ligorio; Abdulmetin Dursun; Jennifer Wargo; Carlos Fernàndez-del Castillo; Andrew Louis Warshaw; Cristina Rosa Ferrone
Journal:  J Gastrointest Surg       Date:  2011-10-18       Impact factor: 3.452

2.  Long-Term Outcomes and Prognostic Factors in Periampullary Carcinoma.

Authors:  Bhanu Jayanand Sunil; Ramakrishnan A Seshadri; S Gouthaman; Rama Ranganathan
Journal:  J Gastrointest Cancer       Date:  2017-03

3.  Pancreatoduodenectomy for tumors of Vater's ampulla: report on 94 consecutive patients.

Authors:  Andrea Di Giorgio; Sergio Alfieri; Fabio Rotondi; Francesco Prete; Dario Di Miceli; Marco Pericoli Ridolfini; Fausto Rosa; Marcello Covino; Giovanni Battista Doglietto
Journal:  World J Surg       Date:  2005-04       Impact factor: 3.352

4.  Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy.

Authors:  Yoo-Seok Yoon; Sun-Whe Kim; Sang Jae Park; Hye Seung Lee; Jin-Young Jang; Min Gew Choi; Woo Ho Kim; Kuhn-Uk Lee; Yong-Hyun Park
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

5.  Pancreaticoduodenectomy in a Latin American country: the transition to a high-volume center.

Authors:  Carlos Chan; Bernardo Franssen; Alethia Rubio; Luis Uscanga
Journal:  J Gastrointest Surg       Date:  2007-09-01       Impact factor: 3.452

6.  Hepatic metastasis from bile duct cancer of the ampulla is effectively controlled by multidisciplinary treatment including S-1, gemcitabine and bevacizumab: A case report.

Authors:  Yukihiko Tokunaga; Toshihiko Kawasaki; Hirokazu Sasaki; Shigeki Matsueda; Tohru Saito
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

7.  A high positive lymph node ratio is associated with distant recurrence after surgical resection of ampullary carcinoma.

Authors:  Christina L Roland; Matthew H G Katz; Graciela M N Gonzalez; Peter W T Pisters; Jean-Nicolas Vauthey; Robert A Wolff; Christopher H Crane; Jeffrey E Lee; Jason B Fleming
Journal:  J Gastrointest Surg       Date:  2012-08-23       Impact factor: 3.452

8.  Usefulness of follow-up after pancreatoduodenectomy for carcinoma of the ampulla of Vater.

Authors:  Laurence Chiche; Barbara Alkofer; Jean-Jacques Parienti; Vincent Rouleau; Ephrem Salamé; Guy Samama; Philippe Segol
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

9.  Sensitivity and specificity of FDG PET-CT scan in detecting lymph node metastasis in operable periampullary tumours in correlation with the final histopathology after curative surgery.

Authors:  Prithivi Raj; Lileswar Kaman; Rajinder Singh; Divya Dahyia; Anish Bhattacharya; Amanjit Bal
Journal:  Updates Surg       Date:  2013-03-16

10.  Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment.

Authors:  Satoshi Kondo; Tadahiro Takada; Masaru Miyazaki; Shuichi Miyakawa; Kazuhiro Tsukada; Masato Nagino; Junji Furuse; Hiroya Saito; Toshio Tsuyuguchi; Masakazu Yamamoto; Masato Kayahara; Fumio Kimura; Hideyuki Yoshitomi; Satoshi Nozawa; Masahiro Yoshida; Keita Wada; Satoshi Hirano; Hodaka Amano; Fumihiko Miura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.